GKSL Share Price | Gujarat Kidney & Super Speciality Ltd Stock Analysis & Recommendation

Q: What does Gujarat Kidney do?

Overview:Gujarat Kidney & Super Speciality Ltd operates in the hospital industry and is classified as a micro-cap company.History:The company was incorporated in 2019 under the name Vihaan Medicare Private Limited. It later changed its name to Gujarat Kidney and Super Speciality Private Limited, with the latest certificate of incorporation issued on September 13, 2023. The most recent quarterly results reported net sales and net profit for the period ending March 2026.Financial Snapshot:Net Sales: 31 Cr (Quarterly Results - Mar 2026) Net Profit: 5 Cr (Quarterly Results - Mar 2026) Market Cap: INR 1,016 Cr (Micro Cap)Key Metrics:P/E: 63.00 Industry P/E: 60 Dividend Yield: 0.00% Debt Equity: -0.11 Return on Equity: 6.14% Price to Book: 4.06 Contact Details:No Company Details Available Registrar Address: Not available.

Q: Should I buy, sell or hold Gujarat Kidney & Super Speciality Ltd?

Based on the current analysis of Gujarat Kidney & Super Speciality Ltd, it would be advisable to hold your position in the company. The company demonstrates a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.18 times. This indicates financial stability.While the long-term growth appears modest, with net sales and operating profit growing at an annual rate of 0%, the recent quarterly results show a positive trend with a 2.87% increase in net sales, reaching Rs 30.58 crore, and a PAT of Rs 5.04 crore, which is the highest recorded.However, the company is considered to have a very expensive valuation, indicated by a high ROCE of 45.9 and an enterprise value to capital employed ratio of 22.7. Despite these valuation concerns, the stock has seen a significant profit increase of 65% over the past year.In summary, holding seems to be the prudent choice at this time, given the company's stable financials and recent positive performance, while also being cautious of its high valuation.

Results Declared: Gujarat Kidney has declared results on 29 May 2026! Click here to unlock the latest financial performance

Mojo Score Change: Gujarat Kidney has changed its score on 29 May 2026. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

4.46 lacs (322.16%) Volume

Shareholding (Mar 2026)

FII

4.88%

Held by 12 FIIs

DII

0.56%

Held by 0 DIIs

Promoter

71.45%

Why is Gujarat Kidney & Super Speciality Ltd falling/rising?

11-Jun-2026

As of 10-Jun, Gujarat Kidney & Super Speciality Ltd's stock price is at 124.00, down 3.84% and has underperformed its sector. Despite a year-to-date gain of 20.68%, recent trends show a significant decline, with a 6.45% drop over the past week and concerns over stagnant sales growth.

View full answer

What does Gujarat Kidney do?

11-Jun-2026

Gujarat Kidney & Super Speciality Ltd, a micro-cap company incorporated in 2019, operates in the hospital industry and reported net sales of 31 Cr and a net profit of 5 Cr for the quarter ending March 2026. Key metrics include a P/E ratio of 63.00 and a market cap of INR 1,016 Cr.

View full answer

Which are the latest news on Gujarat Kidney?

11-Jun-2026

Gujarat Kidney & Super Speciality Ltd is Rated Hold
Gujarat Kidney & Super Speciality Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

How big is Gujarat Kidney?

11-Jun-2026

As of 10th June, Gujarat Kidney & Super Speciality Ltd has a market capitalization of 1,016.00 Cr, with Net Sales of 82.02 Cr and a Net Profit of 15.49 Cr reported in the latest four quarters.

View full answer

Should I buy, sell or hold Gujarat Kidney & Super Speciality Ltd?

31-May-2026

When is the next results date for Gujarat Kidney & Super Speciality Ltd?

12-Feb-2026

The next results date for Gujarat Kidney & Super Speciality Ltd is 14 February 2026.

View full answer

Compare Gujarat Kidney with Similar Stocks

GPT Healthcare Unihealth Hosp Shalby

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.08 times

Healthy long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0%

With a growth in Net Sales of 2.87%, the company declared Very Positive results in Mar 26

With ROE of 6.1, it has a Very Expensive valuation with a 3.9 Price to Book Value

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Hospital

Market cap

INR 988 Cr (Micro Cap)

P/E

63.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.11

Return on Equity

6.14%

Price to Book

3.89

Revenue and Profits:

Net Sales:

31 Cr

(Quarterly Results - Mar 2026)

Net Profit:

5 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

16.94%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Gujarat Kidney for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Gujarat Kidney & Super Speciality Ltd is Rated Hold

Gujarat Kidney & Super Speciality Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Gujarat Kidney & Super Speciality Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent 1.6% decline in the stock price to ₹135.35, the company’s year-to-date return of 31.7% significantly outpaces the Sensex’s negative 12.9%, signalling underlying strength amid short-term technical caution.

Read full news article

Gujarat Kidney & Super Speciality Ltd Quality Parameters Upgrade: A Detailed Fundamental Analysis

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has recently seen its quality grade upgraded from "Does Not Qualify" to "Average" by MarketsMOJO. This shift reflects notable improvements in key business fundamentals such as return on capital employed (ROCE), debt management, and operational efficiency. However, certain areas remain under scrutiny as the company navigates a competitive healthcare landscape. This article delves into the detailed financial metrics and quality parameters that underpin this upgrade, providing investors with a comprehensive view of the company’s evolving fundamentals.

Read full news article

Announcements

Notice Of Postal Ballot

04-Jun-2026 | Source : BSE

Notice of Postal ballot

Announcement under Regulation 30 (LODR)-Newspaper Publication

04-Jun-2026 | Source : BSE

Newspaper Publication for Notice of Postal Ballot

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the year ended on March 31 2026

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

12.54

Debt to EBITDA (avg)

0.92

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.74

Tax Ratio

20.82%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

5.44%

ROCE (avg)

26.45%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.89

EV to EBIT

42.91

EV to EBITDA

35.43

EV to Capital Employed

4.24

EV to Sales

11.64

PEG Ratio

Dividend Yield

ROCE (Latest)

9.87%

ROE (Latest)

6.14%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Mildly Bullish

KST

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 12 FIIs (4.88%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Khandelwal Finance Private Limited (1.67%)

Individual Investors Holdings

10.64%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -5.33% vs 1.24% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -41.20% vs 1.30% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.24",
          "val2": "9.76",
          "chgp": "-5.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.57",
          "val2": "4.14",
          "chgp": "-62.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.29",
          "chgp": "72.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.37",
          "val2": "2.33",
          "chgp": "-41.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.99%",
          "val2": "42.42%",
          "chgp": "-25.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.09",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.42",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.20",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.41%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.85",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.56",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.65",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.53",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.20%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.10",
          "val2": "35.17",
          "chgp": "14.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.14",
          "val2": "15.45",
          "chgp": "4.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.15",
          "val2": "0.53",
          "chgp": "116.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.90",
          "val2": "9.11",
          "chgp": "8.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.25%",
          "val2": "43.93%",
          "chgp": "-3.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

9.24

9.76

-5.33%

Operating Profit (PBDIT) excl Other Income

1.57

4.14

-62.08%

Interest

0.50

0.29

72.41%

Exceptional Items

0.00

Standalone Net Profit

1.37

2.33

-41.20%

Operating Profit Margin (Excl OI)

16.99%

42.42%

-25.43%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -5.33% vs 1.24% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -41.20% vs 1.30% in Dec 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Change(%)

Net Sales

21.09

Operating Profit (PBDIT) excl Other Income

10.42

Interest

0.36

Exceptional Items

0.00

Standalone Net Profit

6.20

Operating Profit Margin (Excl OI)

49.41%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Change(%)

Net Sales

30.85

Operating Profit (PBDIT) excl Other Income

14.56

Interest

0.65

Exceptional Items

0.00

Standalone Net Profit

8.53

Operating Profit Margin (Excl OI)

47.20%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

40.10

35.17

14.02%

Operating Profit (PBDIT) excl Other Income

16.14

15.45

4.47%

Interest

1.15

0.53

116.98%

Exceptional Items

0.00

Standalone Net Profit

9.90

9.11

8.67%

Operating Profit Margin (Excl OI)

40.25%

43.93%

-3.68%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney & Super Speciality Ltd

Micro Cap

Hospital

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.

Company Coordinates

No Company Details Available